Sova Health: Turning Microbiome Data into Personalised Wellness

Problem

Generic supplements and dietary recommendations may not address individual differences in gut microbiomes. Sova aims to bridge this gap through science-backed testing and personalised interventions.

Product

Sova offers gut microbiome and food intolerance testing, expert consultations and customised supplements. Its portfolio also includes Sova X, a personalised probiotic solution based on individual microbiome profiles.

In July 2026, Sova had expanded partnerships with hospitals and wellness clinics, including Sri Ganga Ram Hospital and Medanta. The company also reported revenue growth of 32 times since inception.

Sova was founded by Tanveer Singh & Max Kushnir. Their combined focus on business growth and microbiome science underpins the company's personalised health approach.

Sova's investors include Antler, Goodwater Capital, LetsVenture and Venture Catalysts. The company has not publicly disclosed its total funding in its BioSpectrum India profile.

Sova is focused on expanding partnerships with hospitals, corporate wellness programmes and insurance providers, while growing its direct-to-consumer business. It also aims to build a unified health platform integrating biomarkers, diagnostics, wearables and personalised interventions.

Sova is bringing microbiome science and personalised nutrition into India's growing preventive healthcare market, with a model that links testing, tailored supplements and expert support.

FAST FACTS

Disclaimer: This profile is based on publicly available information and company disclosures. Business performance figures should be verified with the company before publication.